Skip to main content
Skip to content
Case File
efta-efta01519414DOJ Data Set 10Correspondence

EFTA Document EFTA01519414

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01519414
Pages
0
Persons
0
Integrity
No Hash Available
Loading PDF viewer...

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
CHISLAINE MAXWELL ACCT. For the Period 2/1/14 to 2/28/14 Equity Summary Asset Categories Beginning Markel Value Ending Market Value Change In Value Current Allocation US Large Cap Equity 495228.99 489,061.56 (6.147.43) 9% US Small/Mid Cap Equity 15,060.00 14,265.00 (795.00) 1% Non•US Equity 159.92 172.57 1265 1% Preferred Stocks 440,937.00 445,348 00 4 411 00 8% Concentrated & Other Equity 165.640 50 167.266 50 1,626 00 3% Total Value 51,117,026.41 51,116,133.63 ($892.78) 22% Market Value/Cost Current Period Value Markel Value 1,116,133.63 Tax Cost 1,034,682.24 Unrealized Gain/Loss 81,45139 Estimated Annual Income 50,062.72 Accrued Dividends 4,028.00 Yield 4.47% J.P.Morgan Asset Categories US Large Cap Equity Preferred SIOCAS Equity as a percentage of your portfolio 22 % Account Page 5 o' 28 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046700 SDNY_GM_00315898 EFTA01519414

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.